NAOMI JONES: Open Payments
NPI 1790827194 · CASSELBERRY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,223 in 146 payments from 18 companies in 2025. Trend: 2023 $2,313 · 2024 $2,781 · 2025 $2,223
Food & beverage: $2,223
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $325 |
| Corium, LLC | 21 | $323 |
| ABBVIE INC. | 24 | $273 |
| Almatica Pharma LLC | 13 | $245 |
| Otsuka America Pharmaceutical, Inc. | 13 | $219 |
| Validus Pharmaceuticals LLC | 11 | $158 |
| Bausch Health US, LLC | 10 | $147 |
| Lundbeck LLC | 9 | $141 |
| Vanda Pharmaceuticals Inc. | 7 | $122 |
| Collegium Pharmaceutical, Inc. | 3 | $49 |
Products named: CAPLYTA, Azstarys, REXULTI, VRAYLAR, LOREEV XR, APLENZIN, EQUETRO, FANAPT.
Industry payments across FL — which companies pay providers there.
